San Diego, CA -- (SBWIRE) -- 10/22/2013 -- Advaxis, Inc. (OTC:ADXS) declared that it completely exercises over-allotment option. The option was offered to underwriters for purchase of common stock shares totaling 862,500. The option includes additional 431,250 shares.
Advaxis said that the stock was offered at price of $4.00 per share and $0.001 per warrant. Initially the company announced public offering of 750,000 common stock shares and warrants that could buy 2,875,000 common stock shares.The company expects to collect $26,500,000. The offer is made through prospectus only.
Advaxis, Inc. operates in biotechnology industry and manufactures immunotherapies related to cancer and other diseases. Technology used by the company for treatment of HI is also under progress. Advaxis has effectively worked on immunotherapies for cancer types of prostate and HER2 expressing cancers. These HER2 expressing cancers include cancers of breast, bladder, brain, ovary and pancreas.
To see what SuperSmartStocks reflects about Advaxis, Inc. for both short term and long term please click here: ADXS
SuperSmartStocks is all about super stock stars, scouring the markets for parabolic stocks that make epic moves and win colossal gains for investors. Penny Stocks are playing real big moves; SSS catches and reports investors all about gigantic leaps and makes losers the winners! To find out for the latest winning stocks, come and visit the SuperSmartStocks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: SuperSmartStocks.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://SuperSmartStocks.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold SuperSmartStocks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SuperSmartStocks.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SuperSmartStocks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SuperSmartStocks.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. StockSmartStocks.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)